Alexander Mark Schobel - Mar 9, 2023 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Innovation/Tech Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Mar 9, 2023
Transactions value $
$0
Form type
4
Date filed
3/9/2023, 02:07 PM
Previous filing
Nov 8, 2022
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Award $0 +100K +11.33% $0.00 983K Mar 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.